MYGN EBITDA
Myriad Genetics Inc · EBITDA
MYGN EBITDA
Latest reported-$45.20Mperiod ending
MYGN EBITDA (-$7.30M → -$45.20M)
Annual EBITDA
High-resolution chart · PNG
MYGN ebitda history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA (USD) |
|---|---|
| -330,900,000 | |
| -59,500,000 | |
| -197,400,000 | |
| -84,700,000 | |
| 12,300,000 | |
| -123,400,000 | |
| -140,500,000 | |
| 85,000,000 | |
| 177,700,000 | |
| 90,500,000 | |
| 183,100,000 | |
| 160,100,000 | |
| 288,200,000 | |
| 236,900,000 | |
| 189,387,000 | |
| 164,997,000 | |
| 142,159,000 | |
| 135,911,000 | |
| 70,386,000 | |
| -40,183,000 | |
| -38,734,000 | |
| -34,653,000 | |
| -36,869,000 | |
| -22,071,000 | |
| -14,163,621 | |
| -9,407,942 | |
| -8,262,393 | |
| -9,200,000 | |
| -9,700,000 | |
| -10,000,000 | |
| -7,300,000 |